학술논문


EBSCO Discovery Service
발행년
-
(예 : 2010-2015)
전자자료 공정이용 안내

우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.

공정이용 지침
  • 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
  • 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
  • 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
  • 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
  • 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
  • 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
  • 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
  • 상업적·영리적 목적으로 자료를 전송·복제·활용
  • ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
  • EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
  • 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
  • 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
  • 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문' 에서 검색결과 304건 | 목록 1~20
Academic Journal
Genettais D; Institut de Biologie de l'ENS (IBENS), Département de biologie, Ecole normale supérieure, CNRS, INSERM, Université PSL, Paris, France.; Bernard C; Institut Pasteur, Université de Paris, CNRS UMR3525, Microbial Evolutionary Genomics, Paris, France.; Geoffroy F; Société Nationale de Protection de la Nature, Paris, France.; Nizak C; Sorbonne Université, CNRS, Institut de Biologie Paris-Seine, Laboratoire Jean Perrin, Paris, France.; Adiba S; Institut de Biologie de l'ENS (IBENS), Département de biologie, Ecole normale supérieure, CNRS, INSERM, Université PSL, Paris, France.
Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE
Conference
2012 IEEE International Symposium on Industrial Electronics Industrial Electronics (ISIE), 2012 IEEE International Symposium on. :2032-2035 May, 2012
Academic Journal
Fernandez-de-Cossio-Diaz J; Laboratoire de physique de l'Ecole normale supérieure, CNRS, PSL University, Sorbonne Université, Université Paris-Cité, Paris, France.; Uguzzoni G; Italian Institute for Genomic Medicine, IRCCS Candiolo, Candiolo, Italy.; Ricard K; Center for Interdisciplinary Research in Biology (CIRB), Collège de France, CNRS, INSERM, Université PSL, Paris, France.; Anselmi F; Italian Institute for Genomic Medicine, IRCCS Candiolo, Candiolo, Italy.; Department of Life Sciences and Systems Biology & Molecular Biotechnology Center - MBC, Universita di Torino, Via Nizza, Torino, Italy.; Nizak C; Sorbonne Université, CNRS, Institut de Biologie Paris-Seine, Laboratoire Jean Perrin, Paris, France.; Pagnani A; DISAT, Politecnico di Torino, Corso Duca degli Abruzzi, Torino, Italy.; Italian Institute for Genomic Medicine, IRCCS Candiolo, Candiolo, Italy.; INFN, Sezione di Torino, Torino, Via Pietro Giuria, Torino Italy.; Rivoire O; Center for Interdisciplinary Research in Biology (CIRB), Collège de France, CNRS, INSERM, Université PSL, Paris, France.; Gulliver, CNRS, ESPCI Paris, Université PSL, Paris, France.
Publisher: Public Library of Science Country of Publication: United States NLM ID: 101238922 Publication Model: eCollection Cited Medium: Internet ISSN: 1553-7358 (Electronic) Linking ISSN: 1553734X NLM ISO Abbreviation: PLoS Comput Biol Subsets: MEDLINE
Academic Journal
Vojnosanitetski Pregled: Military Medical & Pharmaceutical Journal of Serbia. Jul2019, Vol. 76 Issue 7, p723-727. 5p.
Academic Journal
Paediatria Croatica. 2025 Supplement, Vol. 69, p108-115. 8p.
Academic Journal
Schulz S; Center for Interdisciplinary Research in Biology (CIRB), Collège de France, CNRS UMR 7241, INSERM U1050, PSL University, Paris, France.; Boyer S; Département de biochimie, Faculté de Médecine, Université de Montréal, Montréal, Canada.; Smerlak M; Max Planck Institute for Mathematics in the Sciences, Leipzig, Germany.; Cocco S; Laboratory of Physics of École Normale Supérieure, UMR 8023, CNRS & PSL University, Paris, France.; Monasson R; Laboratory of Physics of École Normale Supérieure, UMR 8023, CNRS & PSL University, Paris, France.; Nizak C; Laboratory of Biochemistry, CBI, UMR 8231, ESPCI Paris, PSL University, CNRS, Paris, France.; Rivoire O; Center for Interdisciplinary Research in Biology (CIRB), Collège de France, CNRS UMR 7241, INSERM U1050, PSL University, Paris, France.
Publisher: Public Library of Science Country of Publication: United States NLM ID: 101238922 Publication Model: eCollection Cited Medium: Internet ISSN: 1553-7358 (Electronic) Linking ISSN: 1553734X NLM ISO Abbreviation: PLoS Comput Biol Subsets: MEDLINE
Academic Journal
Gérard A; HiFiBiO Therapeutics SAS, Paris, France.; Woolfe A; HiFiBiO Therapeutics SAS, Paris, France.; Mottet G; Unit of Antibodies in Therapy and Pathology, Institut Pasteur, UMR1222 INSERM, Paris, France.; Reichen M; HiFiBiO Therapeutics SAS, Paris, France.; Castrillon C; Unit of Antibodies in Therapy and Pathology, Institut Pasteur, UMR1222 INSERM, Paris, France.; École Doctorale Frontières du Vivant (FdV), Centre de Recherches Interdisciplinaires, Paris, France.; Laboratoire de Biochimie (LBC), ESPCI Paris, PSL Research University, CNRS UMR8231 Chimie Biologie Innovation, Paris, France.; Menrath V; HiFiBiO Therapeutics SAS, Paris, France.; Ellouze S; HiFiBiO Therapeutics SAS, Paris, France.; Poitou A; HiFiBiO Therapeutics SAS, Paris, France.; Doineau R; HiFiBiO Therapeutics SAS, Paris, France.; École Doctorale Frontières du Vivant (FdV), Centre de Recherches Interdisciplinaires, Paris, France.; Laboratoire de Biochimie (LBC), ESPCI Paris, PSL Research University, CNRS UMR8231 Chimie Biologie Innovation, Paris, France.; Institute for Integrative Nanosciences, Leibniz IFW Dresden e.V., Dresden, Germany.; Briseno-Roa L; HiFiBiO Therapeutics SAS, Paris, France.; Medetia Pharma, Institut Imagine, Paris, France.; Canales-Herrerias P; Unit of Antibodies in Therapy and Pathology, Institut Pasteur, UMR1222 INSERM, Paris, France.; École Doctorale Frontières du Vivant (FdV), Centre de Recherches Interdisciplinaires, Paris, France.; Laboratoire Colloïdes et Matériaux Divisés (LCMD), ESPCI Paris, PSL Research University, CNRS UMR8231 Chimie Biologie Innovation, Paris, France.; Mary P; HiFiBiO Therapeutics Inc., Cambridge, MA, USA.; Rose G; HiFiBiO Therapeutics Inc., Cambridge, MA, USA.; Ortega C; HiFiBiO Therapeutics Inc., Cambridge, MA, USA.; Delincé M; HiFiBiO Therapeutics Inc., Cambridge, MA, USA.; Essono S; HiFiBiO Therapeutics Inc., Cambridge, MA, USA.; Jia B; Pfizer, Cambridge, MA, USA.; Abbvie Bioresearch Center, Worcester, MA, USA.; Iannascoli B; Unit of Antibodies in Therapy and Pathology, Institut Pasteur, UMR1222 INSERM, Paris, France.; Richard-Le Goff O; Unit of Antibodies in Therapy and Pathology, Institut Pasteur, UMR1222 INSERM, Paris, France.; Kumar R; HiFiBiO Therapeutics Inc., Cambridge, MA, USA.; Stewart SN; HiFiBiO Therapeutics Inc., Cambridge, MA, USA.; Pousse Y; HiFiBiO Therapeutics SAS, Paris, France.; Shen B; HiFiBiO Therapeutics SAS, Paris, France.; Grosselin K; HiFiBiO Therapeutics SAS, Paris, France.; Laboratoire de Biochimie (LBC), ESPCI Paris, PSL Research University, CNRS UMR8231 Chimie Biologie Innovation, Paris, France.; Saudemont B; Unit of Antibodies in Therapy and Pathology, Institut Pasteur, UMR1222 INSERM, Paris, France.; Laboratoire de Biochimie (LBC), ESPCI Paris, PSL Research University, CNRS UMR8231 Chimie Biologie Innovation, Paris, France.; Sautel-Caillé A; Laboratoire de Biochimie (LBC), ESPCI Paris, PSL Research University, CNRS UMR8231 Chimie Biologie Innovation, Paris, France.; Godina A; Laboratoire de Biochimie (LBC), ESPCI Paris, PSL Research University, CNRS UMR8231 Chimie Biologie Innovation, Paris, France.; McNamara S; HiFiBiO Therapeutics SAS, Paris, France.; Eyer K; Laboratoire Colloïdes et Matériaux Divisés (LCMD), ESPCI Paris, PSL Research University, CNRS UMR8231 Chimie Biologie Innovation, Paris, France.; Laboratory for Functional Immune Repertoire Analysis, Institute of Pharmaceutical Sciences, D-CHAB, ETH Zürich, Zurich, Switzerland.; Millot GA; Institut Pasteur, Hub Bioinformatique et Biostatistique, C3BI, USR 3756 IP CNRS, Paris, France.; Baudry J; Laboratoire Colloïdes et Matériaux Divisés (LCMD), ESPCI Paris, PSL Research University, CNRS UMR8231 Chimie Biologie Innovation, Paris, France.; England P; Plateforme de Biophysique Moléculaire, Institut Pasteur, CNRS UMR3528, Paris, France.; Centre d'Innovation et de Technologie, Plateforme de Biophysique des Macromolecules et de leurs Interactions, Institut Pasteur, Paris, France.; Nizak C; Laboratoire de Biochimie (LBC), ESPCI Paris, PSL Research University, CNRS UMR8231 Chimie Biologie Innovation, Paris, France.; Jensen A; HiFiBiO Therapeutics SAS, Paris, France.; Lundbeck A/S, Valby, Denmark.; Griffiths AD; Laboratoire de Biochimie (LBC), ESPCI Paris, PSL Research University, CNRS UMR8231 Chimie Biologie Innovation, Paris, France. andrew.griffiths@espci.fr.; Bruhns P; Unit of Antibodies in Therapy and Pathology, Institut Pasteur, UMR1222 INSERM, Paris, France. pierre.bruhns@pasteur.fr.; Brenan C; HiFiBiO Therapeutics SAS, Paris, France. c.brenan@1cell-bio.com.; HiFiBiO Therapeutics Inc., Cambridge, MA, USA. c.brenan@1cell-bio.com.; 1CellBiO Inc., Watertown, MA, USA. c.brenan@1cell-bio.com.
Publisher: Nature America Publishing Country of Publication: United States NLM ID: 9604648 Publication Model: Print Cited Medium: Internet ISSN: 1546-1696 (Electronic) Linking ISSN: 10870156 NLM ISO Abbreviation: Nat Biotechnol Subsets: MEDLINE; PubMed not MEDLINE
Academic Journal
Gérard A; HiFiBiO Therapeutics SAS, Paris, France.; Woolfe A; HiFiBiO Therapeutics SAS, Paris, France.; Mottet G; Unit of Antibodies in Therapy and Pathology, Institut Pasteur, UMR1222 INSERM, Paris, France.; Reichen M; HiFiBiO Therapeutics SAS, Paris, France.; Castrillon C; Unit of Antibodies in Therapy and Pathology, Institut Pasteur, UMR1222 INSERM, Paris, France.; École Doctorale Frontières du Vivant (FdV), Centre de Recherches Interdisciplinaires, Paris, France.; Laboratoire de Biochimie (LBC), ESPCI Paris, PSL Research University, CNRS UMR8231 Chimie Biologie Innovation, Paris, France.; Menrath V; HiFiBiO Therapeutics SAS, Paris, France.; Ellouze S; HiFiBiO Therapeutics SAS, Paris, France.; Poitou A; HiFiBiO Therapeutics SAS, Paris, France.; Doineau R; HiFiBiO Therapeutics SAS, Paris, France.; École Doctorale Frontières du Vivant (FdV), Centre de Recherches Interdisciplinaires, Paris, France.; Laboratoire de Biochimie (LBC), ESPCI Paris, PSL Research University, CNRS UMR8231 Chimie Biologie Innovation, Paris, France.; Institute for Integrative Nanosciences, Leibniz IFW Dresden e.V., Dresden, Germany.; Briseno-Roa L; HiFiBiO Therapeutics SAS, Paris, France.; Medetia Pharma, Institut Imagine, Paris, France.; Canales-Herrerias P; Unit of Antibodies in Therapy and Pathology, Institut Pasteur, UMR1222 INSERM, Paris, France.; École Doctorale Frontières du Vivant (FdV), Centre de Recherches Interdisciplinaires, Paris, France.; Laboratoire Colloïdes et Matériaux Divisés (LCMD), ESPCI Paris, PSL Research University, CNRS UMR8231 Chimie Biologie Innovation, Paris, France.; Mary P; HiFiBiO Therapeutics Inc., Cambridge, MA, USA.; Rose G; HiFiBiO Therapeutics Inc., Cambridge, MA, USA.; Ortega C; HiFiBiO Therapeutics Inc., Cambridge, MA, USA.; Delincé M; HiFiBiO Therapeutics Inc., Cambridge, MA, USA.; Essono S; HiFiBiO Therapeutics Inc., Cambridge, MA, USA.; Jia B; Pfizer, Cambridge, MA, USA.; Abbvie Bioresearch Center, Worcester, MA, USA.; Iannascoli B; Unit of Antibodies in Therapy and Pathology, Institut Pasteur, UMR1222 INSERM, Paris, France.; Richard-Le Goff O; Unit of Antibodies in Therapy and Pathology, Institut Pasteur, UMR1222 INSERM, Paris, France.; Kumar R; HiFiBiO Therapeutics Inc., Cambridge, MA, USA.; Stewart SN; HiFiBiO Therapeutics Inc., Cambridge, MA, USA.; Pousse Y; HiFiBiO Therapeutics SAS, Paris, France.; Shen B; HiFiBiO Therapeutics SAS, Paris, France.; Grosselin K; HiFiBiO Therapeutics SAS, Paris, France.; Laboratoire de Biochimie (LBC), ESPCI Paris, PSL Research University, CNRS UMR8231 Chimie Biologie Innovation, Paris, France.; Saudemont B; Unit of Antibodies in Therapy and Pathology, Institut Pasteur, UMR1222 INSERM, Paris, France.; Laboratoire de Biochimie (LBC), ESPCI Paris, PSL Research University, CNRS UMR8231 Chimie Biologie Innovation, Paris, France.; Sautel-Caillé A; Laboratoire de Biochimie (LBC), ESPCI Paris, PSL Research University, CNRS UMR8231 Chimie Biologie Innovation, Paris, France.; Godina A; Laboratoire de Biochimie (LBC), ESPCI Paris, PSL Research University, CNRS UMR8231 Chimie Biologie Innovation, Paris, France.; McNamara S; HiFiBiO Therapeutics SAS, Paris, France.; Eyer K; Laboratoire Colloïdes et Matériaux Divisés (LCMD), ESPCI Paris, PSL Research University, CNRS UMR8231 Chimie Biologie Innovation, Paris, France.; Laboratory for Functional Immune Repertoire Analysis, Institute of Pharmaceutical Sciences, D-CHAB, ETH Zürich, Zurich, Switzerland.; Millot GA; Institut Pasteur, Hub Bioinformatique et Biostatistique, C3BI, USR 3756 IP CNRS, Paris, France.; Baudry J; Laboratoire Colloïdes et Matériaux Divisés (LCMD), ESPCI Paris, PSL Research University, CNRS UMR8231 Chimie Biologie Innovation, Paris, France.; England P; Plateforme de Biophysique Moléculaire, Institut Pasteur, CNRS UMR3528, Paris, France.; Centre d'Innovation et de Technologie, Plateforme de Biophysique des Macromolecules et de leurs Interactions, Institut Pasteur, Paris, France.; Nizak C; Laboratoire de Biochimie (LBC), ESPCI Paris, PSL Research University, CNRS UMR8231 Chimie Biologie Innovation, Paris, France.; Jensen A; HiFiBiO Therapeutics SAS, Paris, France.; Lundbeck A/S, Valby, Denmark.; Griffiths AD; Laboratoire de Biochimie (LBC), ESPCI Paris, PSL Research University, CNRS UMR8231 Chimie Biologie Innovation, Paris, France. andrew.griffiths@espci.fr.; Bruhns P; Unit of Antibodies in Therapy and Pathology, Institut Pasteur, UMR1222 INSERM, Paris, France. pierre.bruhns@pasteur.fr.; Brenan C; HiFiBiO Therapeutics SAS, Paris, France. c.brenan@1cell-bio.com.; HiFiBiO Therapeutics Inc., Cambridge, MA, USA. c.brenan@1cell-bio.com.; 1CellBiO Inc., Watertown, MA, USA. c.brenan@1cell-bio.com.
Publisher: Nature America Publishing Country of Publication: United States NLM ID: 9604648 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-1696 (Electronic) Linking ISSN: 10870156 NLM ISO Abbreviation: Nat Biotechnol Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[검색어] Nizak, C.
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어